Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
Paying user area
Try for free
Amgen Inc. pages available for free this week:
- Statement of Comprehensive Income
- Cash Flow Statement
- Common-Size Income Statement
- Analysis of Profitability Ratios
- Analysis of Liquidity Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Price to FCFE (P/FCFE)
- Price to Operating Profit (P/OP) since 2005
- Price to Book Value (P/BV) since 2005
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Amgen Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Amgen Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)
Based on: 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).
The capital structure of the organization is characterized by a high degree of leverage, with total liabilities consistently representing a dominant portion of the total liabilities and stockholders’ equity. Total liabilities fluctuated between a low of 85.07% in March 2021 and a peak of 98.45% in March 2022. While leverage remains elevated, a gradual downward trend in total liabilities is observable from 2023 onward, concluding at 87.78% by June 2026.
- Long-Term Debt and Noncurrent Liabilities
- Long-term debt, excluding the current portion, serves as the primary driver of the liability profile. This component increased from 49.78% in March 2021 to a peak of 68.49% in March 2023, before steadily declining to 54.22% by June 2026. Correspondingly, total noncurrent liabilities peaked at 77.95% in March 2023 and decreased to 61.11% by the end of the period. A notable reduction is observed in long-term tax liabilities, which fell from 11.25% in March 2021 to approximately 2.97% by June 2026.
- Current Liability Trends
- Current liabilities exhibit cyclical volatility, ranging from a low of 16.02% in March 2023 to a high of 28.14% in September 2025. Accrued liabilities remain a significant component of current obligations, typically fluctuating between 13% and 20%. The current portion of long-term debt shows intermittent spikes, particularly in early 2021 and mid-2024, indicating periodic shifts in debt maturity profiles.
- Stockholders’ Equity and Retained Earnings
- Stockholders’ equity experienced a severe contraction, dropping from 14.93% in March 2021 to a minimum of 1.55% in March 2022. Following this trough, a slow recovery trend is evident, with equity rising to 12.22% by June 2026. This recovery is mirrored by a reduction in the accumulated deficit, which peaked at -49.95% in March 2022 and narrowed to -23.29% by June 2026. Common stock and additional paid-in capital also saw a structural decline, moving from above 50% in 2021 to a range of 35% to 38% from 2023 through 2026.
- Comprehensive Loss and Other Liabilities
- Accumulated other comprehensive loss remained relatively stable and small, generally oscillating between -0.12% and -1.45%. Long-term deferred tax liabilities emerged as a recorded item in late 2023, maintaining a low presence between 1.36% and 2.42% of the total balance sheet through June 2026.